Pubdate: Mon, 16 May 2016 Source: Province, The (CN BC) Page: 4 Copyright: 2016 Postmedia Network Inc. Contact: http://www.theprovince.com/ Details: http://www.mapinc.org/media/476 Author: Tiffany Crawford DOCTOR-PRESCRIBED HEROIN GETS GREEN LIGHT FROM B.C. GROUPS Health officials in B.C. are applauding the federal government for taking steps to allow doctors to prescribe heroin for certain patients. Health Canada said Friday it will propose a regulatory amendment to allow access to prescription heroin, or diacetylmorphine, under Health Canada's special-access program. "A significant body of scientific evidence supports the medical use of diacetylmorphine, also known as pharmaceutical-grade heroin, for the treatment of chronic relapsing opioid dependence," Health Canada said in a release. Diacetylmorphine is permitted in other countries, including Germany, the Netherlands, Denmark and Switzerland, to support a small number of patients who haven't responded to other treatment options. Providence Health Care, which operates the Crosstown Clinic in Vancouver, and the Pivot Legal Society welcomed the announcement, and said in a joint statement that allowing doctors to prescribe pharmaceutical-grade heroin is an important step in the treatment of chronic opioid dependence. "Allowing access to diacetylmorphine, or medical heroin, to patients who need it, ensures that life-saving treatments get delivered to vulnerable people suffering from chronic opioid use," the statement said. Providence said the law would allow doctors to consider requests for access to drugs for patients with serious or life-threatening conditions when conventional treatments have failed. Providence, along with a group of patients, filed a constitutional challenge in 2014 with the Supreme Court of B.C. and won a temporary injunction that allowed the Crosstown Clinic, in Vancouver's Downtown Eastside, to dispense medical heroin to existing patients, who were previously participants in a clinical study. The Study to Assess Longer-term Opioid Medication Effectiveness, or SALOME, recruited 202 heroin users who had a documented drug addiction for at least five years. The users were randomly divided into two groups and given syringes filled with pharmaceutically prepared hydromorphone, the opioid pain medication sold under the brand name Dilaudid, or diacetylmorphine, the active ingredient in heroin. Requests by the clinic to keep administering the medical heroin to participants after the studies led to legal conflicts with the former Conservative government, which had taken a hard line against allowing prescription heroin. The Conservatives claimed it was in direct opposition to the government's anti-drug policy and violated the intent of the program. Crosstown Clinic physician Scott MacDonald has said providing heroin as medication is cheaper for society than the legal and medical price of drug addiction. He said a single drug-addicted person costs taxpayers at least $45,000 a year in petty crime, policing, courts, jail time and health care, while administering either medical heroin or hydromorphone in Crosstown's supervised clinic costs about $27,000 a patient a year, mostly in staff wages. - --- MAP posted-by: Jo-D